[pp.int.general] ( pharmaceutical ) patents

[coretx at piratenpartij.nl]

I suggest that all that are working on ( pharmaceutical ) patent issues
take a look @ the following document.

http://www.cepr.net/documents/publications/intellectual_property_2004_09.pdf

CEPR - Center for Economical and Policy research.
Financing Drug Research: What are the issues ? - By Dean Baker.

Here is his list of used references:

  
Baker, D. and N. Chatani, 2002. "Promoting Good Ideas on Drugs: Are Patents
the Best 
Way? " Center for Economic and Policy Research, 
[http://www.cepr.net/promoting_good_ideas_on_drugs.htm]. 
 
Dimasi, J. and H Grabowski, 2004. "Patents and R&D Frameworks: Comments on
the 
Hubbard and Love Trade Framework for Financing Pharmaceutical R&D." Tufts
Center 
for the Study of Drug Development, Tufts University 
[http://www.who.int/intellectualproperty/news/en/Submission3.pdf]. 
Dimasi J. R. Hansen, and H. Grabowski, 2003. "The Price of Innovation: New
Estimates 
of Drug Development Costs." Journal of Health Economics, 22 151-185. 
Ernst & Young LLP. 2001. Pharmaceutical Industry R&D Costs: Key Findings
about the 
Public Citizen Report. Pharmaceutical Research and Manufacturers of
America. 
[http://www.phrma.org/press/newsreleases/2001-08-11.277.pdf].   
Hay, J. and D. Zammit 2002. “Vaccine Policy Perspectives: Market
Strategies.” 
University of Southern California, paper prepared for the Institute of
Medicine, 
Committee on Evaluation of Vaccine Purchase Finance in the United States.  
Hollis, A. 2004. "An Efficient Reward System for Pharmaceutical
Innovation." 
Unpublished Manuscript, Department of Economics, University of Calgary.  
Hubbard, T. and J. Love, 2004. "A New Trade Framework for Global Healthcare
R&D." 
Plos Biology, V2, #2. [http://www.plosbiology.org/plosonline/?request=get- 
document&doi=10.1371%2Fjournal.pbio.0020052]  
 
Kremer, M. 2000. "Creating Markets For New Vaccines, Part I: Rationale,"
National 
Bureau of Economic Research Working Paper # 7716. 
 
Kremer, M. 1998. "Patent Buyouts: A Mechanism for Encouraging Innovation:
Quarterly 
Journal of Economics. 113, 1137-1167. 
  
Kucinich, D. 2004. "The Free Market Drug Act of 2004."  
 
Love, J. 2003. "From TRIPS to RIPS: A Better Trade Framework to Support
Innovation 
in Medical Technologies."
[http://www.cptech.org/ip/health/rndlf/trips2rips.pdf].